Variant report
Variant | nsv590739 |
---|---|
Chromosome Location | chr3:79704831-79756484 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:79708743..79711096-chr3:79711481..79714388,3 | MCF-7 | breast: | |
2 | chr3:79733600..79735105-chr3:79743459..79746281,2 | MCF-7 | breast: | |
3 | chr3:79708743..79711096-chr3:79711481..79714388,3 | MCF-7 | breast: | |
4 | chr3:79733600..79735105-chr3:79743459..79746281,2 | MCF-7 | breast: | |
5 | chr3:79751071..79751988-chr6:4044472..4045061,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184523867 | chr3:79711010-79711011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530547750 | chr3:79711024-79711025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145183744 | chr3:79711027-79711028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189393679 | chr3:79711031-79711032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182239684 | chr3:79711036-79711037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371630778 | chr3:79711057-79711058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200727152 | chr3:79711077-79711078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531778699 | chr3:79711101-79711102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550890477 | chr3:79711131-79711132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35686616 | chr3:79711156-79711157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140250941 | chr3:79711177-79711178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78413157 | chr3:79711263-79711264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539241244 | chr3:79711381-79711382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375389812 | chr3:79711539-79711540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567604187 | chr3:79711559-79711560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77439636 | chr3:79711567-79711568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540845186 | chr3:79711589-79711590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186154868 | chr3:79711597-79711598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536053122 | chr3:79711649-79711650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574884913 | chr3:79711714-79711715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs537496720 | chr3:79711730-79711731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558009444 | chr3:79711751-79711752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs578223842 | chr3:79711792-79711793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540441113 | chr3:79711793-79711794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189005756 | chr3:79711804-79711805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574006881 | chr3:79711836-79711837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149146419 | chr3:79711860-79711861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553132919 | chr3:79711869-79711870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181368308 | chr3:79711874-79711875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368399503 | chr3:79711888-79711889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185847249 | chr3:79711899-79711900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369051945 | chr3:79711914-79711915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531715209 | chr3:79711928-79711929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545452124 | chr3:79711930-79711931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191336010 | chr3:79711941-79711942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532596596 | chr3:79711949-79711950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs117499389 | chr3:79711972-79711973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559372215 | chr3:79720866-79720867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532582438 | chr3:79720882-79720883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528582195 | chr3:79720883-79720884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552891068 | chr3:79720899-79720900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555586778 | chr3:79720930-79720931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34254787 | chr3:79720949-79720950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9809381 | chr3:79720962-79720963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs374403516 | chr3:79721019-79721020 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537502462 | chr3:79721099-79721100 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538438786 | chr3:79721109-79721110 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549799062 | chr3:79721114-79721115 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569942473 | chr3:79721119-79721120 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554869616 | chr3:79721213-79721214 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:79711000-79712000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr3:79711200-79712000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:79711600-79712000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr3:79711600-79712000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr3:79720800-79721000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr3:79721000-79721400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:79721000-79721600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr3:79721000-79722000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr3:79721000-79722000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr3:79721000-79722200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr3:79721000-79722200 | Enhancers | Brain Germinal Matrix | brain |
12 | chr3:79734200-79734600 | Enhancers | HepG2 | liver |
13 | chr3:79744600-79745000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr3:79753400-79753800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr3:79753400-79754200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr3:79753400-79754200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr3:79753800-79754200 | Enhancers | HUES64 Cell Line | embryonic stem cell |